Preclinical evaluation of antisense oligonucleotide therapy in a mouse model of HNRNPH2-related neurodevelopmental disorder

Journal:
Science Translational Medicine
Published:
DOI:
10.1126/scitranslmed.adx3491
Affiliations:
5
Authors:
13
Go to article
Institutions Authors Share
St. Jude Children's Research Hospital (St. Jude), United States of America (USA)
10.000000
10.000000
 0.77
Ionis Pharmaceuticals, United States of America (USA)
3.000000
 0.23
Interested in Oncology and Carcinogenesis?